Medicinal Products

ALFUZOSINE LP BIOGARAN 10 mg

Generic drug of Xatral LP
Therapeutic class: Urology nephrology
active ingredients: Alfuzosin
laboratory: Biogaran

Sustained release tablet
Box of 30
All forms

Indication

- Treatment of functional symptoms of benign prostatic hypertrophy. - Bladder adjuvant treatment in acute urine retention related to benign prostatic hypertrophy.

Dosage ALFUZOSINE LP BIOGARAN 10 mg prolonged release tablet Box of 30

Oral way.
- The tablet should be swallowed whole, without being crunched, with a glass of water (see section warnings and precautions for use).
- The recommended dosage is 1 10 mg tablet daily, to be taken immediately after the evening meal.
- Bladder adjuvant treatment in acute urine retention related to benign prostatic hypertrophy:
The recommended dosage is 1 10 mg tablet daily, to be taken after the meal, from the first day of urethral catheterization.
The treatment is administered for 3 to 4 days including 2 to 3 days during the catheterization and 1 day after the withdrawal of the latter.

Against indications

CONTRAINDICATED:
Hypersensitivity to alfuzosin and / or any of the excipients.
- Orthostatic hypotension.
- Hepatic insufficiency.
- Severe renal insufficiency (creatinine clearance <30 ml / min).
- The therapeutic indication does not concern the woman.
NOT RECOMMENDED :
Associations advised against : antihypertensive alpha blockers (prazosin, urapidil, minoxidil); ketoconazole, itraconazole, ritonavir, clarithromycin, erythromycin.

Side effects Alfuzosine LP Biogaran

- CNS disorders and psychiatric disorders:
. Frequent (> = 1% - <10%) : dizziness, dizziness, malaise, headache.
. Uncommon (> = 0.1% - <1%) : dizziness, drowsiness.
- Cardiovascular disorders:
. Uncommon (> = 0.1% - <1%) : tachycardia, palpitations, orthostatic hypotension, syncope.
. Very rare (<0.01%) : angina pectoris in patients with a history of coronary artery disease (see section cautionary statements and precautions for use).
- Respiratory system disorders:
Uncommon (> = 0.1% - <1%) : nasal congestion.
- Gastrointestinal disorders:
. Frequent (> = 1% - <10%) : nausea, abdominal pain.
. Uncommon (> = 0.1% - <1%) : diarrhea, dry mouth.
- Skin manifestations:
. Uncommon (> = 0.1% - <1%) : rash, pruritus.
. Very rare (<0.01%) : urticaria, angioneurotic edema.
- General events:
. Frequent (> = 1% - <10%) : asthenia.
. Uncommon (> = 0.1% - <1%) : flushes, edema, chest pain (see section cautionary statements and precautions for use).

Popular Posts

Category Medicinal Products, Next Article